EXCITATORY AMINO ACID REGULATION OF VASOPRESSIN CELLS
加压素细胞的兴奋性氨基酸调节
基本信息
- 批准号:2262533
- 负责人:
- 金额:$ 19.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-07-01 至 1996-12-31
- 项目状态:已结题
- 来源:
- 关键词:electron microscopy embryo /fetus tissue /cell culture excitatory aminoacid glutamate receptor glutamates hormone regulation /control mechanism immunocytochemistry in situ hybridization innervation laboratory rat neuroendocrine system neurons peptide hormone biosynthesis radioimmunoassay receptor binding supraoptic nucleus tissue /cell culture vasopressins
项目摘要
Our studies will focus on the chemical and physiological factors which
control the secretion of vasopressin by magnocellular neurons in the
hypothalamic supraoptic nucleus. These factors will be identified,
characterized and an attempt will be made to relate these to the osmotic
regulation of vasopressin secretion. The use of an in vitro approach with
the hypothalamo-neurohypophysial complex (HNC) will give the degree of
control necessary to achieve these goals. The HNC contains the entire
supraoptic-neuroendocrine final common pathway including the two intact
supraoptic nuclei (NSO), the supraoptico-neurohypophysial tract (SOHT) and
the neurosecretory terminals of the neural lobe (NL). Every major site
suspected of being involved in the osmotic regulation of vasopressin
secretion is present in the HNC. The HNC explant retains osmosensitivity
in vitro and can approach in vivo responsiveness. Thus, the entire
functional pathway is present for the exploration of the functional
integration of osmotic stimuli and the transduction of this information at
the level of the supraoptic nucleus. We will characterize the release of
vasopressin and establish the conditions which allow precise temporal and
semi-quantitative analys of responsiveness via the SOHT. Effects of
chemical and osmotic stimuli and their interactions will be characterized
and will include screening for the effects of various putative
neurotransmitters on the release of vasopressin (cholinergic, angiotensin
II, norepinephrine, enkephalin, dopamine). In particular, we will focus on
the specific contribution of the NSO with particular emphasis on the
nicotinic cholinergic system which has been strongly implicated in the
control of vasopressin secretion. The localization of putative nicotinic
receptors on vasopressin-containing magnocellular neurons in NSO will be
examined. Parallel experiments will be run to assess specific properties
of these receptors which may contribute to osmotic sensitivity of the NSO.
Investigation of the electrophysiological properties of identified cells in
the NSO during chemical and osmotic challenges will provide detailed
temporal comparison of the physiological responses with the release of
vasopressin. Concomitant double- and triple-labeling procedures on
dye-marked neurons will be used for cytoarchitectonic reconstruction and
electron microscopic analysis of synaptic inputs on
immunocytochemically-identified neurons in the NSO. Thus, the HNC explant
represents a simple, viable, highly controlled mammalian neural system in
which unknown physiological processes express their effects on a well
defined final pathway. Ideal neuroendocrine control system.
我们的研究将集中在化学和生理因素
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICK B MEEKER其他文献
RICK B MEEKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICK B MEEKER', 18)}}的其他基金
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
研究确定 LM11A-31 作为神经保护剂对老年艾滋病毒感染者和抗逆转录病毒治疗神经认知障碍患者的安全性、耐受性和可行性
- 批准号:
10762833 - 财政年份:2023
- 资助金额:
$ 19.82万 - 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
- 批准号:
10204135 - 财政年份:2018
- 资助金额:
$ 19.82万 - 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
- 批准号:
9975935 - 财政年份:2018
- 资助金额:
$ 19.82万 - 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
- 批准号:
9751991 - 财政年份:2018
- 资助金额:
$ 19.82万 - 项目类别:
Neural network dysfunction in early HIV neuropathogenesis
HIV早期神经发病机制中的神经网络功能障碍
- 批准号:
10448257 - 财政年份:2018
- 资助金额:
$ 19.82万 - 项目类别:
A degradomics strategy for the analysis of inflammation-associated neuronal vulnerability
分析炎症相关神经元脆弱性的降解组学策略
- 批准号:
9374952 - 财政年份:2017
- 资助金额:
$ 19.82万 - 项目类别:
LM11A-31 neuroprotective efficacy in an animal model of HIV
LM11A-31 在 HIV 动物模型中的神经保护功效
- 批准号:
8896088 - 财政年份:2014
- 资助金额:
$ 19.82万 - 项目类别:
LM11A-31 neuroprotective efficacy in an animal model of HIV
LM11A-31 在 HIV 动物模型中的神经保护功效
- 批准号:
8789501 - 财政年份:2014
- 资助金额:
$ 19.82万 - 项目类别:














{{item.name}}会员




